Microencapsulated Multicell Tumor Spheroids

微囊化多细胞肿瘤球体

基本信息

  • 批准号:
    01870085
  • 负责人:
  • 金额:
    $ 8.96万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1991
  • 项目状态:
    已结题

项目摘要

The purpose of this investitgation is to establish the assay system in vivo for evaluating the therapeutic effect of radiation or drugs on malignant solid tumors.1. Method of microcapsules FormationWe tried to set up the system for making microcapsules of perfect spherical shape using sodium alginate and poly-L-lysine. The size and shape of the microcapsules, membrane permeability depended on the degree of polymerization and sterilization method of the alginate, shape of air jet nozzle, flow rate of air and molecular weight of poly-L-lysine. It was concluded for obtaining microcapsules of about 500 mum diameter to use the sodium alginate of polymerization degree 118 and viscosity of 500 CP at 1% solution, the sterilization by filtration. The stability and permeability of the membrance was better to use poly-L-lysine of MW 22, 000 than that of lower or higher molecular weight.2. Proliferation of Cancer Cells and In Vivo Transplantation.Human cancer cells encapsulated in the microcapsules proliferated rapidly in situ to forny a multicell tumor spheroid in vitro. When these capsules were transplanted either intraperitoneally or subcutaneously, numerous blood cells were attached to the surface of the microcapsules and it became difficult to recover these microcapsules from mice with a longer time interval.3. Cell Survival Assay.A linear proportional relationship was obtained between the number of cells plated per well and the mean optical density per well. The slope of the curve depended upon the surviving fraction of cells. Using this relationship. ' the survival curves of GBA-7 and TE-2 human cancer cells against the dose of X-ray were obtained. The result indicates that GBA-7 cells were more resistant to X-ray than TE-2 cells which is comparable to that obtained from the colony forming assay.
本研究的目的是建立评价放射线或药物对恶性实体瘤治疗效果的体内测定系统。 1.微胶囊的形成方法我们尝试建立使用海藻酸钠和聚-L-赖氨酸制造完美球形微胶囊的系统。微胶囊的尺寸和形状、膜的渗透性取决于海藻酸盐的聚合度和灭菌方法、空气喷嘴的形状、空气的流速和聚-L-赖氨酸的分子量。结论是采用聚合度118、粘度500CP的海藻酸钠1%溶液,过滤除菌,即可得到直径约500μm的微胶囊。使用MW 22, 000的聚L-赖氨酸膜的稳定性和渗透性优于较低或较高分子量的膜。 2.癌细胞增殖和体内移植。封装在微胶囊中的人类癌细胞在体外迅速原位增殖,形成多细胞肿瘤球体。当这些胶囊被移植到腹腔或皮下时,大量的血细胞附着在微胶囊的表面,并且在较长的时间间隔内从小鼠中回收这些微胶囊变得困难。 3.细胞存活测定。每孔铺板的细胞数与每孔平均光密度之间获得线性比例关系。曲线的斜率取决于细胞的存活分数。利用这种关系。获得GBA-7和TE-2人类癌细胞相对于X射线剂量的存活曲线。结果表明,GBA-7 细胞比 TE-2 细胞对 X 射线具有更强的抵抗力,这与集落形成测定中获得的结果相当。

项目成果

期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Kuroda et al: "Unusual survival kinetics of neocarcinostatin-treated HeLa cells:Its relation to the drug-inactivation" J.Radiat.Res.32. 191-201 (1991)
Y.Kuroda 等人:“新制癌素处理的 HeLa 细胞的异常生存动力学:与药物失活的关系”J.Radiat.Res.32。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sasaki, T., Miura, M.: "Biological evaluation of chemo-radiotherapy combined with cisplatin." Jpn. J. Cancer Clin.36. 2234-2243 (1990)
Sasaki, T.,Miura, M.:“放化疗联合顺铂的生物学评价。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Kuroda et al: "Unusual survival kinetics of neocarcinostatin-treated HeLa cells : Its relation to the drug-inactivation" J.Radiat.Res.32. 191-201 (1991)
Y.Kuroda 等人:“新制癌素处理的 HeLa 细胞的异常生存动力学:其与药物失活的关系”J.Radiat.Res.32。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
三浦 雅彦他: "細胞の放射線抵抗性に関与する内在性SH化合物の役割" 口病誌. 58. 320-320 (1991)
Masahiko Miura 等人:“内源性 SH 化合物在细胞放射抗性中的作用”口腔医学杂志 58. 320-320 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
三浦 雅彦,佐々木 武仁: "マウス扁平上皮癌細胞の内因性放射線抵抗性へのグルタチオンの関与" 日本医放 生物部会誌. 3. 87-88 (1990)
Masahiko Miura、Takehito Sasaki:“谷胱甘肽参与小鼠鳞状细胞癌细胞的固有放射抗性”日本放射线放射学生物学部杂志 3. 87-88 (1990)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SASAKI Takehito其他文献

SASAKI Takehito的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SASAKI Takehito', 18)}}的其他基金

CONTROL MECHANISM OF RADIORESISTANT HYPOXIC CELLS IN MUTICELLULAR TUMOR SPHEROIDS
多细胞肿瘤球体中抗辐射缺氧细胞的控制机制
  • 批准号:
    10470399
  • 财政年份:
    1998
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
ELECTRONIC FILING AND APPLICATION OF INTRAORAL RADIOGRAPHIC IMAGES IN DENTAL INFORMATION SYSTEM
口腔X线图像电子归档及在牙科信息系统中的应用
  • 批准号:
    09557148
  • 财政年份:
    1997
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of PCNA in Repair of Radiation-induced DNA Damage
PCNA 在修复辐射诱导的 DNA 损伤中的作用
  • 批准号:
    07457446
  • 财政年份:
    1995
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Quantitative Analysis on CT image in maxillofacial Region
颌面部CT图像的定量分析
  • 批准号:
    01480463
  • 财政年份:
    1989
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

I-Corps: Translation potential of using machine learning to predict oxaliplatin chemotherapy benefit in early colon cancer
I-Corps:利用机器学习预测奥沙利铂化疗对早期结肠癌疗效的转化潜力
  • 批准号:
    2425300
  • 财政年份:
    2024
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Standard Grant
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
  • 批准号:
    23K26797
  • 财政年份:
    2024
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A novel medical device for reducing chemotherapy-induced peripheral neuropathy in the hands
一种减少化疗引起的手部周围神经病变的新型医疗设备
  • 批准号:
    MR/Z503800/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Research Grant
Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer
保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力
  • 批准号:
    MR/Y011783/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Fellowship
Bone Marrow Adipogenesis in Response to Chemotherapy and Resultant Effect on Bone Metastasis
骨髓脂肪生成对化疗的反应及其对骨转移的影响
  • 批准号:
    491636
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Miscellaneous Programs
Exploring the molecular function of HIKESHI in pancreatic cancer tumor development and response to thermal/chemotherapy.
探索 HIKESHI 在胰腺癌肿瘤发展和热/化疗反应中的分子功能。
  • 批准号:
    23K14610
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia
低强度超声的临床前测试作为预防化疗引起的脱发人源化小鼠模型中紫杉醇引起的毛囊损伤的新策略
  • 批准号:
    10722518
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
精氨酸消耗联合铂类紫杉烷化疗对侵袭性变异前列腺癌 (AVPC) 的影响
  • 批准号:
    10715329
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Impact of Obesity on Chemotherapy-Induced Cytotoxicity: Immune Cells and Skeletal Muscle
肥胖对化疗引起的细胞毒性的影响:免疫细胞和骨骼肌
  • 批准号:
    10572695
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
Endothelial Smad3 as a Novel Target to Avert Chemotherapy Induced Cardiomyopathy
内皮 Smad3 作为避免化疗引起的心肌病的新靶点
  • 批准号:
    10730342
  • 财政年份:
    2023
  • 资助金额:
    $ 8.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了